HEALWELL AI to Acquire BioPharma, One of Canada's Largest CROs, to Expand and AI-Enable Clinical Research Offerings
HEALWELL has entered into an agreement to acquire BioPharma Services Inc., one of the largest full-service Contract Research Organizations ("CRO") headquartered in Canada. BioPharma is focused on bioequivalence and early-stage clinical trials, with over 2,200 clinical trials completed to date with approximately 250 pharma clients since inception. BioPharma is expected to generate between $35 to $40 Million of revenue in 2024 with approximately 5% EBITDA1 operating margins based on YTD...
2024-06-13 7:00 AM EDT
WELL Health Launches 'WELL AI Decision Support' Powered by HEALWELL AI; Empowering Healthcare Providers with Next Generation Decision Support Systems
WELL announces the launch of WELL AI Decision Support, to assist healthcare providers in improving early disease diagnosis and preventative health. WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis to power its solutions both in Canada and the US. WELL's goal is to make AI Enabled Decision Support a core offering to all physicians supported by its fully managed and SaaS platforms which collectively power more than 31,000 physicians and other care...
2023-10-18 8:00 AM EDT
HEALWELL AI Announces Closing of $8 Million Bought Deal Private Placement
Toronto, Ontario--(Newsfile Corp. - October 17, 2023) - HEALWELL AI Inc. (TSX: AIDX) ("HEALWELL" or the "Company") is pleased to announce that it has closed its previously announced "bought deal" private placement financing of 13,333,400 Class A subordinate voting shares of the Company (the "Shares") at a price of $0.60 per Share, for aggregate gross proceeds of $8,000,040 (the "Offering"). The Offering was conducted on a "bought deal" private placement basis by Eight Capital, as lead...
2023-10-17 9:15 AM EDT